Home › Neurologic Diseases › NCT06883227

Investigating Health Impacts of Exposure to Harmful Algal Blooms

Who can join

Ages 18 and older · All sexes · Healthy volunteers welcome

Inclusion Criteria:

1. Subject should be able to provide written informed consent.
2. Adult aged 18 or older.
3. Resident (temporary or permanent) of one of the following five southwest Florida counties (Lee, Collier, Charlotte, Sarasota, or Manatee).
4. Any race or ethnicity.
5. Willing to return for at least a total of four study visits and participate in all required procedures for the duration of the study.

Exclusion Criteria:

1. Inability to speak or write in English.
2. Any medical condition for which the study investigator believes enrollment is medically inappropriate.
3. Unwilling/unable to provide biological samples or poor venous access.

About the study

The goals of this project are to study the biological effects of environmental toxins (ET), in particular aquatic toxins such as brevetoxins (PbTx) and microcystin or their metabolites. This study is designed to examine the effects of the body from harmful algae blooms (HAB) as well as possibility of an association between exposure to the marine toxin, brevetoxin (PbTx), which is released from K. brevis during the red tide bloom, and the prevalence of neurological illnesses.

Sponsor: Roskamp Institute Inc. · Participants: 400 · Started: Oct 14, 2024

Contact the study team

• Dakota Helgager Clinical Research Site Coordinator, Bachelor's · Phone: 9412568010
• Ayse Cemek Clinical Research Coordinator, Bachelors · Phone: 9412568010

Official record on ClinicalTrials.gov — NCT06883227

Locations in the U.S.

Conditions

• Neurologic Diseases
• Mental Fatigue
• Cough

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.